PCOS Awareness Month Recognition

Summary#

This House resolution recognizes polycystic ovary syndrome (PCOS) as a serious health disorder that affects many aspects of health, including reproductive, metabolic, and mental health. It notes estimates that 5,000,000 to 10,000,000 women in the United States have PCOS and cites global prevalence estimates of 8 to 13 percent. The resolution lists common symptoms and related health risks, including infertility, irregular periods, acne, excess hair growth, insulin resistance, type 2 diabetes, cardiovascular disease, nonalcoholic fatty liver disease, and endometrial cancer. It supports designating the month of September as "PCOS Awareness Month," calls for better diagnosis, treatment, research, and care, and encourages States, territories, and localities to support awareness efforts. The resolution was introduced in the House and referred to the Committee on Energy and Commerce.

What it means for you#

If you are affected by PCOS or care for someone who is, this resolution seeks to raise public awareness about the condition and its health risks. It asks healthcare professionals and researchers to improve diagnosis, treatment, and information about PCOS and encourages local and state groups to promote awareness activities during September. The resolution itself does not change medical care rules or provide new services.

Expenses#

The resolution does not authorize new federal spending or appropriate funds. No publicly available information on government costs or new appropriations is included in the text. The resolution does cite a 2004 study estimating the annual burden of PCOS in the United States at $4,360,000,000 for women's reproductive years, as published in the bill text.

Proponents' View#

According to the resolution, supporters want to increase awareness and education about PCOS among the public, women and girls, and health professionals; improve diagnosis and treatment; share information on managing PCOS and preventing related conditions (such as type 2 diabetes and endometrial cancer); improve quality of life and health outcomes; and encourage more research into causes, treatments, and a cure.

Opponents' View#

No publicly available information on opposition or objections is included in the resolution text.